Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Uda

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 11, 2017
Tocilizumab postpones the start of hemodialysis compared to conventional oral treatment in amyloid A amyloidosis patients with advanced renal insufficiency by suppressing serum SAA levelsHiroshi Uda, Osamu Saiki
Clinical and Experimental Rheumatology|February 24, 2017
Successful extension of tocilizumab infusion intervals from 4 weeks to 6 or 5 weeks in 90% of RA patients with good response to 4-week intervalsOsamu Saiki, Hiroshi Uda
Rheumatology International|September 13, 2018
Efficacy and safety of extending intravenous tocilizumab intervals from 4 to 6 weeks in rheumatoid arthritis patients with good response to 4-week intervalsOsamu Saiki, Hiroshi Uda
Scandinavian Journal of Immunology|November 19, 2021
Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseasesOsamu Saiki, Hiroshi Uda
Modern Rheumatology|January 17, 2025
The serum amyloid A to C-reactive protein ratio is lower in men than in women because of higher-C-reactive protein concentrations in menHiroshi Uda, Michihito Katayama, Keiji Maeda, et al.
Modern Rheumatology|November 18, 2021
Discrepancy between SAA and CRP levels linked to the difference of SAA/CRP ratio in the patients with early rheumatoid arthritisHiroshi Uda, Rika Ebisu, Keiji Maeda, et al.
BMJ Case Reports|August 11, 2011
Progression of viraemia during treatment with infliximab in a patient with rheumatoid arthritis and chronic hepatitis C infectionHiroshi Uda, Makihiko Kuhara, Norihiro Nishimoto, et al.
Inflammation|August 3, 2011
Evaluation of lasting high levels of CRP among the patients with metabolic syndromeOsamu Saiki, Makihiko Kuhara, Nozomi Kikuchi, et al.
The Journal of Rheumatology|September 6, 2007
Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritisOsamu Saiki, Rikio Takao, Yuko Naruse, et al.
Surgical Neurology International|June 5, 2020
Burr hole drainage without irrigation for chronic subdural hematomaHiroshi Uda, Alhusain Nagm, Tsutomu Ichinose, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 11, 2017
Tocilizumab postpones the start of hemodialysis compared to conventional oral treatment in amyloid A amyloidosis patients with advanced renal insufficiency by suppressing serum SAA levelsHiroshi Uda, Osamu Saiki
Clinical and Experimental Rheumatology|February 24, 2017
Successful extension of tocilizumab infusion intervals from 4 weeks to 6 or 5 weeks in 90% of RA patients with good response to 4-week intervalsOsamu Saiki, Hiroshi Uda
Rheumatology International|September 13, 2018
Efficacy and safety of extending intravenous tocilizumab intervals from 4 to 6 weeks in rheumatoid arthritis patients with good response to 4-week intervalsOsamu Saiki, Hiroshi Uda
Scandinavian Journal of Immunology|November 19, 2021
Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseasesOsamu Saiki, Hiroshi Uda
Modern Rheumatology|January 17, 2025
The serum amyloid A to C-reactive protein ratio is lower in men than in women because of higher-C-reactive protein concentrations in menHiroshi Uda, Michihito Katayama, Keiji Maeda, et al.
Modern Rheumatology|November 18, 2021
Discrepancy between SAA and CRP levels linked to the difference of SAA/CRP ratio in the patients with early rheumatoid arthritisHiroshi Uda, Rika Ebisu, Keiji Maeda, et al.
BMJ Case Reports|August 11, 2011
Progression of viraemia during treatment with infliximab in a patient with rheumatoid arthritis and chronic hepatitis C infectionHiroshi Uda, Makihiko Kuhara, Norihiro Nishimoto, et al.
Inflammation|August 3, 2011
Evaluation of lasting high levels of CRP among the patients with metabolic syndromeOsamu Saiki, Makihiko Kuhara, Nozomi Kikuchi, et al.
The Journal of Rheumatology|September 6, 2007
Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritisOsamu Saiki, Rikio Takao, Yuko Naruse, et al.
Surgical Neurology International|June 5, 2020
Burr hole drainage without irrigation for chronic subdural hematomaHiroshi Uda, Alhusain Nagm, Tsutomu Ichinose, et al.
Pageof 5